We are live on ! Find out more
CC

Caxton Corporation Portfolio holdings

AUM $4.02M
1-Year Est. Return 256.08%
This Fund
S&P 500
This Quarter Est. Return
-2.6%
1 Year Est. Return
+256.08%
3 Year Est. Return
+777.99%
5 Year Est. Return
+744.68%
10 Year Est. Return
+18,621.85%
AUM
$122M
AUM Growth
-$1.06M
Cap. Flow
+$5.5M
Cap. Flow %
4.49%
Top 10 Hldgs %
73.33%
Holding
57
New
2
Increased
26
Reduced
3
Closed
5

Top Buys

Rank Stock Value
1
XERS icon
Xeris Biopharma Holdings
XERS
+$13.6M
2
PSTH
Pershing Square Tontine Holdings, Ltd.
PSTH
+$4.5M
3
RZLT icon
Rezolute
RZLT
+$4.49M
4
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
+$3.03M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.61M

Top Sells

Rank Stock Value
1
SBBP
Strongbridge Biopharma plc.
SBBP
+$16.4M
2
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
+$3.96M
3
KALA icon
KALA BIO
KALA
+$3.19M
4
GIGGU
GigCapital4, Inc. Unit
GIGGU
+$459K
5
SWBK.U
Switchback II Corporation Units, each consisting of one Class A ordinary share and one fifth of one
SWBK.U
+$398K

Sector Composition

Rank Sector Weight
1 Healthcare 66.24%
2 Financials 10.38%
3 Communication Services 4.24%
4 Technology 3.26%
5 Consumer Discretionary 1.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FLACW
51
DELISTED
Frazier Lifesciences Acquisition Corporation Warrant
FLACW
$12K 0.01%
21,333
– –
PV.WS
52
DELISTED
Primavera Capital Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PV.WS
$8K 0.01%
12,000
– –
CZOO.WS
53
DELISTED
Cazoo Group Ltd Redeemable Warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
CZOO.WS
– –
-62,500
Closed -$94K
BOAS.U
54
DELISTED
BOA Acquisition Corp. Units, each consisting of one share of Class A common stock, and one third of one redeemable warrant
BOAS.U
– –
-34,070
Closed -$337K
GIGGU
55
DELISTED
GigCapital4, Inc. Unit
GIGGU
– –
-45,000
Closed -$459K
SWBK.U
56
DELISTED
Switchback II Corporation Units, each consisting of one Class A ordinary share and one fifth of one
SWBK.U
– –
-39,000
Closed -$398K
SBBP
57
DELISTED
Strongbridge Biopharma plc.
SBBP
– –
-8,024,542
Closed -$16.4M
1 2
3

Similar funds

PCM
Pathway Capital Management Irvine, California $4.3M AUM 62.8% 1-Year Est. Return
RA
Ritter Alpha New York $4.78M AUM
CGA
Compound Global Advisors Mercer Island, Washington $3.22M AUM 30.08% 1-Year Est. Return
HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
ABA
American Beacon Advisors Irving, Texas $5.08M AUM 20.11% 1-Year Est. Return
UOMF
University of Maryland Foundation Adelphi, Maryland $5.1M AUM 10.69% 1-Year Est. Return
KI
Khan Imran $2.93M AUM
1IC
1922 Investment Company Houston, Texas $2.92M AUM 1.93% 1-Year Est. Return

Caxton Corporation's Q4 2021 Portfolio in Review

As of Q4 2021, Caxton Corporation held 57 positions worth $122M, down 0.86% from $123M the previous quarter. Its ten largest holdings account for 73% of the portfolio.

Caxton Corporation deployed $5.5M of net new capital in Q4 2021, opening 2 new positions and adding to 26 existing holdings. Its largest new stake was Xeris Biopharma Holdings: 6,310,546 shares worth $18.5M.

By sector, the portfolio is most concentrated in Healthcare at 66% of assets, down from 73% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was Sierra Oncology, Inc. Common Stock, an estimated $3.96M trimmed.

  • Caxton Corporation's largest Q4 2021 buy was Xeris Biopharma Holdings: 6,310,546 shares worth $18.5M.
  • Caxton Corporation added most to Rezolute in Q4 2021, an estimated $4.49M increase.
  • Caxton Corporation's biggest Q4 2021 reduction was Sierra Oncology, Inc. Common Stock, cutting an estimated $3.96M.
  • Caxton Corporation fully exited Strongbridge Biopharma plc. in Q4 2021, selling an estimated $16.4M.
  • Caxton Corporation's ten largest holdings make up 73% of its $122M portfolio in Q4 2021.
  • Caxton Corporation opened 2 new positions and closed 5 in Q4 2021.
  • Caxton Corporation's portfolio value fell 0.86% quarter-over-quarter to $122M.

Based on Caxton Corporation's 13F filing for Q4 2021, filed 14 Feb 2022.